The Journal of Organic Chemistry
Article
ethan-1-ol (14.2 μL, 0.1 mmol, 1 equiv). The title compound was
obtained as a white solid (40% yield, 4:1 dr − NMR). MP: 129.0−
131.0 °C; TLC: Rf = 0.36 in 20% EtOAc/hexanes; IR (neat) ν
(cm−1): 2923, 1604, 1494, 1470, 1437, 1371, 1336, 1307, 1276, 1256,
Following GP1, the compound was formed using 2-(4-
methoxyphenyl)ethan-1-ol (15.2 mg, 0.1 mmol, 1 equiv). The title
compound was obtained as an off-white solid (55% yield, 1.5:1 dr −
NMR). MP: 110.0−112.0 °C; TLC: Rf = 0.15 in 10% EtOAc/
pentane; IR (neat) ν (cm−1): 2959, 2925, 2852, 1613, 1516, 1463,
1
1224, 1184; H NMR (CDCl3, 400 MHz) δ (ppm): 7.71 (d, J = 8.1
1
Hz, 1H), 7.56−7.54 (m, 2H), 7.34−7.30 (m, 1H), 7.09−7.06 (m,
2H), 6.90−6.87 (m, 1H), 5.24 (ap t, J = 9.0 Hz, 1H), 4.70−4.65 (m,
1H), 4.39−4.34 (m, 1H), 3.83 (s, 3H), 2.53 (s, 3H); 13C NMR
(CDCl3, 150 MHz) δ (ppm): 160.3, 145.7, 137.7, 134.6, 133.9, 131.9,
1333, 1181, 1109, 828, 760; H NMR (CDCl3, 600 MHz) δ (ppm):
Major diastereomer - 7.69 (d, J = 8.0 Hz, 1H), 7.60−7.53 (m, 2H),
7.30 (d, J = 8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.30 (dd, J = 8.9,
5.7 Hz, 1H), 4.64−4.60 (m, 1H), 4.41 (ap t, J = 8.4 Hz, 1H), 3.81 (s,
3H), 2.53 (s, 3H). Minor diastereomer - 7.78 (d, J = 8.3 Hz, 1H),
7.60−7.53 (m, 2H), 7.49 (d, J = 8.1 Hz, 1H), 7.43 (d, J = 8.8 Hz,
1H), 6.94 (d, J = 8.9 Hz, 2H), 5.20 (ap t, J = 8.4 Hz, 1H), 4.64−4.60
(m, 1H), 4.36 (ap t, J = 8.7 Hz, 1H), 3.82 (s, 3H), 2.53 (s, 3H); 13C
NMR (CDCl3, 150 MHz) δ (ppm): 160.1, 160.0, 145.7, 145.5, 135.6,
134.7, 133.9, 133.5, 132.0, 130.7, 129.6, 128.3, 127.8, 125.9, 125.7,
123.6, 123.4 (J1CF = 289.7 Hz), 123.2 (J1CF = 287.1 Hz), 121.7, 121.0,
114.6, 114.1, 97.6 (J2CF = 34.4 Hz), 96.9 (J2CF = 34.4 Hz), 72.7, 65.4,
34.5, 55.5, 55.4, 22.0, 21.9; 19F NMR (CDCl3, 377 MHz) δ (ppm):
Major diastereomer - 78.9, Minor diastereomer - 78.5; HRMS (m/z
ESI-TOF): calculated for C18H16F3NO4SNa+ ([M + Na]+) 422.0650,
found 422.0637.
130.3, 129.8, 125.9, 123.3 (q, J1 = 284.1 Hz), 121.7, 119.0, 114.3,
CF
112.3, 97.8 (q, J2 = 32.6 Hz), 64.5, 55.4, 22.0; 19F NMR (CDCl3,
CF
565 MHz) δ (ppm): Major diastereomer - 78.4, Minor diastereomer -
78.9; HRMS (m/z ESI-TOF): calculated for C18H16F3NO4SNa+ ([M
+ Na]+) 422.0650, found 422.0643.
8-Methyl-9b-(trifluoromethyl)-3-(3-(trifluoromethyl)phenyl)-2,3-
dihydro-9bH-benzo[4,5]isothiazolo[3,2-b]oxazole 5,5-Dioxide (13).
Following GP1, the compound was formed using 2-(3-
(trifluoromethyl)phenyl)ethan-1-ol (15.2 μL, 0.1 mmol, 1 equiv).
The title compound was obtained as an off-white solid (20.7 mg, 47%
yield, >20:1 dr). MP: 141.0−142.0 °C; TLC: Rf = 0.31 in 20%
EtOAc/pentane; IR (neat) ν (cm−1): 2919, 2850, 1735, 1599, 1457,
1378, 1329, 1270, 1254, 1223; 1H NMR (CDCl3, 600 MHz) δ
(ppm): 7.80 (d, J = 7.8 Hz, 1H), 7.72 (d, J = 7.8 Hz, 1H), 7.68 (s,
1H), 7.64 (d, J = 8.1 Hz, 1H), 7.59−7.55 (m, 3H), 5.32 (ap t, J = 8.2
Hz, 1H), 4.73−4.69 (m, 1H), 4.40−4.35 (m, 1H), 2.54 (s, 3H); 13C
NMR (CDCl3, 150 MHz) δ (ppm): 146.0, 137.4, 134.4, 134.1, 131.7,
131.6 (q, J2CF = 32.6 Hz), 130.2, 129.4, 125.9, 125.8 (J3CF = 3.7 Hz),
(3R,9bR)-8-Methyl-3-(p-tolyl)-9b-(trifluoromethyl)-2,3-dihydro-
9bH-benzo[4,5]isothiazolo[3,2-b]oxazole 5,5-Dioxide (17). Follow-
ing GP1, the compound was formed using 2-(p-tolyl)ethan-1-ol (13.8
μL, 0.1 mmol, 1 equiv). The title compound was obtained as an off-
white solid (80% yield, 2:1 dr − NMR). MP: 130.0−132.0 °C; TLC:
Rf = 0.18 in 10% EtOAc/pentane; IR (neat) ν (cm−1): 2961, 2924,
1
124.0 (q, J1CF = 272.5 Hz), 123.7 (q, J3CF = 3.7 Hz), 123.3 (q, J1
=
1514, 1334, 1224, 1181, 992, 816; H NMR (CDCl3, 600 MHz) δ
CF
287.8 Hz), 121.8, 97.9 (q, J2CF = 34.5 Hz), 76.9, 64.1, 22.0; 19F NMR
(CDCl3, 565 MHz) δ (ppm): −62.7, −78.4; HRMS (m/z ESI-TOF):
calculated for C18H13F6NO3SNa+ ([M + Na]+) 460.0418, found
460.0415.
(ppm): Major diastereomer - 7.69 (d, J = 8.0 Hz, 1H), 7.56−7.47 (m,
2H), 7.40 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 7.9 Hz, 2H), 5.22 (ap t, J =
8.5 Hz, 1H), 4.67−4.61 (m, 1H), 4.43−4.33 (m, 1H), 2.53 (s, 3H),
2.37 (s, 3H); Minor diastereomer - 7.61 (bs, 1H), 7.56−7.47 (m, 2H),
7.27 (d, J = 7.2 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 5.31 (dd, J = 8.6,
5.8 Hz, 1H), 4.67−4.61 (m, 1H), 2.53 (s, 3H), 2.35 (s, 3H); 13C
NMR (CDCl3, 150 MHz) δ (ppm): 145.7, 145.6, 138.8, 138.6, 135.5,
134.7, 133.5, 133.0, 132.0, 130.7, 129.9, 129.4, 129.0, 128.0, 126.8,
125.9, 125.7, 123.4 (J1CF = 289.3 Hz), 123.2 (J1CF = 286.2 Hz), 121.7,
121.0, 97.7 (J2 = 34.4 Hz), 96.9 (J2 = 32.9 Hz), 72.7, 65.5, 64.7,
8-Methyl-9b-(trifluoromethyl)-3-(4-(trifluoromethyl)phenyl)-2,3-
dihydro-9bH-benzo[4,5]isothiazolo[3,2-b]oxazole 5,5-Dioxide (14).
Following GP1, the compound was formed using 2-(4-
(trifluoromethyl)phenyl)ethan-1-ol (15.2 μL, 0.1 mmol, 1 equiv).
The title compound was obtained as an off-white solid (30.2 mg, 69%
yield, >20:1 dr). MP: 138.0−140.0 °C; TLC: Rf = 0.38 in 20%
EtOAc/pentane; IR (neat) ν (cm−1): 2914, 1623, 1600, 1478, 1428,
CF
CF
22.0, 21.9, 21.4, 21.3; 19F NMR (CDCl3, 565 MHz) δ (ppm): Major
diastereomer - 78.4, Minor diastereomer - 78.9; HRMS (m/z ESI-
TOF): calculated for C18H16F3NO3SNa+ ([M + Na]+) 406.0701,
found 406.0688.
1
1337, 1323, 1303, 1257, 1225, 1175, 1149, 1104; H NMR (CDCl3,
400 MHz) δ (ppm): 7.72−7.55 (m, 7H), 5.33 (ap t, J = 8.0 Hz, 1H),
4.72 (ap t, J = 8.0 Hz, 1H), 4.37 (ap t, J = 8.8 Hz, 1H), 2.54 (s, 3H);
13C NMR (CDCl3, 150 MHz) δ (ppm): 160.3, 146.0, 140.3, 134.3,
134.1, 131.7, 131.1 (q, J2 = 32.7 Hz), 127.2, 126.2 (q, J3 = 3.9
8-Methyl-3-(pyridin-2-yl)-9b-(trifluoromethyl)-2,3-dihydro-9bH-
benzo[4,5]isothiazolo[3,2-b] Oxazole 5,5-Dioxide (18). Following
GP1, the compound was formed using 2-pyridineethanol (11.3 μL,
0.1 mmol, 1 equiv), but the amination proceeded in only 8 h (rather
than 24 h). The title compound was obtained as an off-white solid
(49% yield, 6:1 dr − NMR). MP: 125.0−127.0 °C; TLC: Rf = 0.08 in
10% EtOAc/pentane; IR (neat) ν (cm−1): 3022, 2963, 2926, 2854,
CF
CF
Hz), 125.9, 125.9, 124.1 (q, J1 = 272.8 Hz), 123.3 (q, J1 = 288.5
CF
CF
Hz), 121.8, 97.9 (q, J2 = 34.2 Hz), 64.0, 22.0; 19F NMR (CDCl3,
CF
377 MHz) δ (ppm): −62.7, −78.4; HRMS (m/z ESI-TOF):
calculated for C18H13F6NO3SNa+ ([M + Na]+) 460.0418, found
460.0415.
1
1598, 1475, 1355, 1215, 1183, 748; H NMR (CDCl3, 600 MHz) δ
3-(4-Fluorophenyl)-8-methyl-9b-(trifluoromethyl)-2,3-dihydro-
9bH-benzo[4,5]isothiazolo[3,2-b]oxazole 5,5-Dioxide (15). Follow-
ing GP1, the compound was formed using 2-(4-fluorophenyl)ethan-1-
ol (12.5 μL, 0.1 mmol, 1 equiv). The title compound was obtained as
an off-white solid (34.8 mg, 49% yield, 5:1 dr − NMR). MP: 136.0−
138.0 °C; TLC: Rf = 0.13 in 10% EtOAc/pentane; IR (neat) ν
(cm−1): 2963, 2917, 2851, 1735, 1606, 1512, 1334, 1181, 1151, 976,
835. 1H NMR (CDCl3, 600 MHz) δ (ppm): 7.70 (d, J = 8.2 Hz, 1H),
7.57−7.47 (m, 4H), 7.13−7.08 (m, 2H), 5.23 (ap t, J = 8.4 Hz, 1H),
4.68−4.63 (m, 1H), 4.37−4.32 (m, 1H), 2.53 (s, 3H); 13C NMR
(CDCl3, 150 MHz) δ (ppm): 163.9, 162.2, 145.8, 145.7, 135.5, 134.5,
(ppm): 8.57−8.55 (m, 1H), 7.82−7.78 (m, 2H), 7.75 (d, J = 7.9 Hz,
1H), 7.58−7.56 (m, 2H), 7.31 (d, J = 7.3 Hz, 1H), 5.52 (ap t, J = 7.4
Hz, 1H), 4.80−4.72 (m, 2H), 2.54 (s, 3H); 13C NMR (CDCl3, 150
MHz) δ (ppm): 157.3, 149.4, 146.0, 137.6, 134.4, 133.9, 131.8, 125.9,
123.1 (q, J1CF = 287.1 Hz), 123.1, 121.7, 121.0, 96.1 (J2CF = 32.7 Hz),
75.5, 64.1, 22.0; 19F NMR (CDCl3, 565 MHz) δ (ppm): −78.7;
HRMS (m/z ESI-TOF): calculated for C16H14F3N2O3S+ ([M + H]+)
371.0672, found 371.0674.
3-Isopropyl-8-methyl-9b-(trifluoromethyl)-2,3-dihydro-9bH-
benzo[4,5]isothiazolo[3,2-b]oxazole 5,5-Dioxide (19). Following
GP1, the compound was formed using 3-methyl-1-butanol (11.0
μL, 0.1 mmol, 1 equiv). The title compound was obtained as a white
solid (37% yield, 2.3:1, β:γ − NMR). MP: 97.0−99.0 °C; TLC: Rf =
0.44 in 20% EtOAc/hexanes; IR (neat) ν (cm−1): 2968, 2923, 2851,
134.0, 133.6, 132.3, 131.9, 131.6, 130.7, 130.0 (d, J2 = 9.1 Hz),
CF
128.7 (d, J2 = 8.6 Hz), 125.9, 125.8, 123.4 (q, J1 = 287.8 Hz),
CF
123.1 (q, J1CCFF = 289.2 Hz), 121.8, 121.5, 121.1, 116.2 (d, J1CF = 21.1
Hz), 115.8 (d, J1 = 21.3 Hz), 97.7 (q, J2 = 34.1 Hz), 72.9, 67.8,
CF
CF
1
65.0, 64.1, 22.1, 22.0; 19F NMR (CDCl3, 565 MHz) δ (ppm): Major
diastereomer - 78.5, −113.3, Minor diastereomer - 78.9−112.3;
HRMS (m/z ESI-TOF): calculated for C17H13F4NO3SNa+ ([M +
Na]+) 410.0450, found 410.0437.
1598, 1467, 1341, 1322, 1304, 1256, 1173, 1158; H NMR (CDCl3,
400 MHz) δ (ppm): 7.70 (d, J = 8.0 Hz, 1H), 7.52 (d, J = 8.2 Hz,
1H), 7.49 (s, 1H), 4.25−4.20 (m, 2H), 4.01−3.96 (m, 1H), 2.50 (s,
3H), 1.97−1.91 (m, 1H), 1.18 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 6.7
Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ (ppm): 145.6, 134.6, 133.7,
131.9, 125.7, 123.1 (q, J1 = 287.2 Hz), 121.6, 97.7 (q, J2 = 34.0
3-(4-Methoxyphenyl)-8-methyl-9b-(trifluoromethyl)-2,3-dihy-
dro-9bH-benzo[4,5]isothiazolo [3,2-b]oxazole 5,5-Dioxide (16).
CF
CF
F
J. Org. Chem. XXXX, XXX, XXX−XXX